| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000214407.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.033762002 |
Resistant |
| ENSG00000214407.3 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.031328303 |
Resistant |
| ENSG00000214407.3 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.047206251 |
Sensitive |
